"10.1371_journal.pone.0111901","plos one","2014-11-10T00:00:00Z","Elena V Rosca; Marie-France Penet; Noriko Mori; Jacob E Koskimaki; Esak Lee; Niranjan B Pandey; Zaver M Bhujwalla; Aleksander S Popel","Department of Biomedical Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, United States of America; Johns Hopkins University In-vivo Cellular and Molecular Imaging Center Program, Division of Cancer Imaging Research, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, United States of America; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, United States of America","Conceived and designed the experiments: EVR MFP JEK NBP ZMB ASP. Performed the experiments: EVR MFP JEK NM EL NBP. Analyzed the data: EVR MFP JEK NBP. Wrote the paper: EVR MFP.","Dr. Aleksander S. Popel serves as the CSO of AsclepiX Therapeutics, LLC; the terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies. Drs. Elena V. Rosca, Jacob E. Koskimaki, Niranjan B. Pandey, and Aleksander S. Popel are co-inventors on patents on materials and methods used in this study (Mimetic Peptides Derived from Collagen Type Iv and Their Use for Treating Angiogenesis- and Lymphagiogenesis-dependent Diseases WO2012079088A2 and US20130316950A1). The other authors declare no competing interests. This information does not alter the authors adherence to all PLOS ONE policies on sharing data and materials, as detailed online in PLOS ONE guide for authors.","2014","11","Elena V Rosca","EVR",8,FALSE,6,6,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
